AbbVie ' s Humira Downfall Is Swift As Biosimilars Hammer Away At Sales

stock crumbled Thursday after the first approved biosimilar copycat to launch in the U.S. hammered away at Humira's legendary sales. X Though Amgen's (AMGN) biosimilar, dubbed Amjevita, launched halfway through the first quarter, global sales of immunology blockbuster Humira slumped more than 25%…#humira #amgen #amgn #rickgonzalez #abbvie #rinvoq #leebrown #thirdbridge #robmichael #marketsmithcom
Source: Reuters: Health - Category: Consumer Health News Source Type: news